Harvey B Pollard

USPTO Granted Patents = 14 (Patent Applications = 2)

EPO Patents = 1 (Patent Applications = 2)

Average Co-Inventor Count = 1.9

ph-index = 5

Forward Citations = 111(Granted Patents)

Company Filing History:

5 out of 192

The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc.

patents

2 out of 1,217

The United States of America As Represented by the Department of Health

patents

1 out of 30

National Institutes of Health (nih)

patents

4. 1 out of 2,202

The United States of America As Represented by the Secretary of

patents

5. 6 out of 832,812

Other

patents

where one patent can have more than one assignee

Years Active: 1987-2021

Loading Chart...

14 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11085934 - Biomarkers for diagnosing post traumatic stress disorder (2021-08-10),

2. 10358679 - MicroRNA biomarkers for posttraumatic stress disorder and methods of use thereof (2019-07-23),

3. 7893094 - Amphiphilic pyridinium compounds, method of making and use thereof (2011-02-22),

4. 7504223 - Knockout mouse for the tumor suppressor gene ANX7 (2009-03-17),

5. 6747187 - Knockout mouse for the tumor suppressor gene ANX7 (2004-06-08),

6. 6491655 - Methods for treating hemophilia A and B and AIDS and devices used therein (2002-12-10),

7. 6174299 - Method for treating hemophilia A and B and AIDS and devices used therein (2001-01-16),

8. 6083954 - Method of treating cystic fibrosis (2000-07-04),

9. 5908399 - Methods for treating hemophilia A and B and AIDS and devices used therein (1999-06-01),

10. 5877179 - Xanthines for identifying CFTR--binding compounds useful for activating (1999-03-02),

11. 5366977 - Method of treating cystic fibrosis using (1994-11-22),

12. 5112957 - Method and apparatus for washing solid media (1992-05-12),

13. 4753635 - Inducing analgesia by implantation of cells releasing neuroactive (1988-06-28),

14. 4670394 - Isolation and culture of adrenal medullary endothelial cells producing (1987-06-02),

Title: **Harvey B Pollard: Pioneering Innovator in Biomarker Research**

Introduction

Harvey B Pollard, based in Potomac, MD, is an esteemed inventor with a remarkable portfolio of 14 patents. His innovative work primarily focuses on the diagnosis and treatment of post-traumatic stress disorder (PTSD), contributing significantly to the field of mental health research through his inventive approaches.

Latest Patents

Pollard's latest patents are groundbreaking, centering on the use of biomarkers for diagnosing PTSD. One of his notable inventions, titled "Biomarkers for diagnosing post traumatic stress disorder," introduces methodologies to determine whether an individual is at risk of developing PTSD. His subsequent patent, "MicroRNA biomarkers for posttraumatic stress disorder and methods of use thereof," discloses comprehensive methods for detecting and diagnosing PTSD in human subjects. This patent also addresses monitoring PTSD progression, treatment strategies for patients, and includes kits designed for diagnosing PTSD, all while highlighting the detection of miRNAs in biological samples.

Career Highlights

Throughout his career, Pollard has collaborated with various reputable organizations, including The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc. His inventions not only bolster the understanding of PTSD but also provide vital tools for clinicians working in the mental health arena.

Collaborations

In his innovative journey, Pollard has had the pleasure of working alongside distinguished colleagues such as Kenneth Alan Jacobson and Meera Srivastava. These collaborations have undoubtedly enriched his research and broadened the scope of his inventions.

Conclusion

Harvey B Pollard's contributions to the field of biomarker research for PTSD demonstrate his dedication to improving mental health outcomes. With a portfolio of patents that showcases his inventive spirit, Pollard plays a critical role in advancing the tools used for diagnosing and treating this complex condition. His work stands as a testament to the power of innovation in addressing vital health issues.

This text is generated by artificial intelligence and may not be accurate.